Start-up spirit. Experienced leadership. A mission of change. Ichnos (‘īk-nōz) Sciences—a name taken from an ancient Greek word for “footprint”—is shifting how the world thinks about innovation in medicine. With a new approach to the research, discovery, and development of breakthrough therapies in oncology and autoimmune disease, we’re forging a new path forward. We aim to treat disease holistically, seeking to provide curative therapies that extend human life and improve quality of life. Science SHIFTED…from now on. Headquartered in the NYC metro area with additional teams in Switzerland, ours is a mission rooted in purpose and aimed at progress. Ichnos Sciences is fast-paced, forward-looking and visionary—a company where science, creativity, and a diversity of ideas thrive. We move quickly and nimbly, working together, challenging and supporting one another and ourselves to go further, look deeper, take scientific risks, shift perspectives, and drive forward the scientific advances that will leave an imprint on the world around us. At Ichnos Sciences, we dare to imagine a world where cure is possible. And we invite you to join us. Because cure is possible.
|
|
|
|
|
51-200 employees
View all Ichnos Sciences employees
|
|
|
biotechnology
|
|
|
$10M–$50M
|
|
|
+1 617-864-3000
|
|
|
1 World Trade Center,New York,NY,US
|
|
|
2019
|
Cyril Konto is the CEO of Ichnos Sciences.
The decision makers in Ichnos Sciences are Adam Drake, Ann Marie Assumma, Cyril Konto, etc. Click to Find Ichnos Sciences decision makers emails.
Ichnos Sciences headquarters is located at 1 World Trade Center,New York,NY,US.
Ichnos Sciences generates an estimated $10M–$50M annually, based on industry analysis and publicly available market data.
You can contact Ichnos Sciences by calling +1 617-864-3000.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.